TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15559 · Mar 14

#java#docker#mybatis#oss#springboot#vue RuoYi-Vue-Plus is a free, open-source backend framework upgraded from RuoYi for distributed clusters and multi-tenant use, built with Spring Boot 3.5, Vue3, TypeScript, MyBatis-Plus, and Redisson. It offers superior features like plugin decoupling, advanced permissions, multi-database support, workflows, code generation, Docker deployment, monitoring, and data security tools—far beyond original RuoYi. You benefit by building scalable enterprise apps 80% faster with less code, easier maintenance, and robust security for production. Warning: Versions ≤5.5.3 have critical flaws (CVE-2025-66916 RCE, CVE-2026-2819 auth bypass); update immediately. https://github.com/dromara/RuoYi-Vue-Plus

Results

1 similar post found

Search: #bitdca

当前筛选 #bitdca清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 02/26/2025, 01:00 PM

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement